KDOQI US commentary on the 2012 KDIGO clinical practice guideline for acute kidney injury

American Journal of Kidney Diseases

Volumn 61, Issue 5, 2013, Pages 649-672

  Palevsky, Paul M ^a   Liu, Kathleen D ^b   Brophy, Patrick D ^c   Chawla, Lakhmir S ^d   Parikh, Chirag R ^e,f   Thakar, Charuhas V ^g,h   Tolwani, Ashita J ⁱ   Waikar, Sushrut S ^j   Weisbord, Steven D ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CINCINNATI   (United States)

^h UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

ⁱ University of Alabama at Birmingham   (United States)

^j BRIGHAM AND WOMEN S HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ALBUMIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIFUNGAL AGENT; ATRIAL NATRIURETIC FACTOR; BICARBONATE; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; DOBUTAMINE; DOPAMINE; ECHINOCANDIN; ELECTROLYTE; FENOLDOPAM; GADOLINIUM; HYPERTENSIVE FACTOR; INSULIN; MANNITOL; NONSTEROID ANTIINFLAMMATORY AGENT; NORADRENALIN; PYRROLE DERIVATIVE; RECOMBINANT SOMATOMEDIN C; SODIUM CHLORIDE; THEOPHYLLINE; TOBRAMYCIN; UNINDEXED DRUG;

ACUTE KIDNEY FAILURE; BACTERIAL ENDOCARDITIS; CALORIC INTAKE; CARDIOGENIC SHOCK; CHRONIC KIDNEY DISEASE; CLINICAL EFFECTIVENESS; COLLOID; CONTINUOUS RENAL REPLACEMENT THERAPY; CONTRAST INDUCED NEPHROPATHY; COST EFFECTIVENESS ANALYSIS; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CRITICALLY ILL PATIENT; CRYSTALLOID; DISEASE CLASSIFICATION; DISEASE COURSE; DISEASE DURATION; DRUG CONTRAINDICATION; DRUG COST; DRUG FATALITY; DRUG MONITORING; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; ENTEROCOCCAL INFECTION; EVIDENCE BASED PRACTICE; FLUID RESUSCITATION; GLYCEMIC CONTROL; GROUPS BY AGE; HEALTH CARE QUALITY; HEART ARRHYTHMIA; HEMODIALYSIS; HEMOFILTRATION; HEPATORENAL SYNDROME; HUMAN; HYPERGLYCEMIA; HYPERVOLEMIA; INTENSIVE CARE; INTRAVENOUS ADMINISTRATION; LIVER DISEASE; LOW DRUG DOSE; MYCOSIS; NEPHROTOXICITY; NUTRITIONAL SUPPORT; OFF PUMP CORONARY SURGERY; PARASITOSIS; PARENTERAL NUTRITION; PERINATAL ASPHYXIA; PRACTICE GUIDELINE; PREVENTIVE MEDICINE; PROGNOSIS; PROTEIN RESTRICTION; RENAL REPLACEMENT THERAPY; RESUSCITATION; REVIEW; RISK FACTOR; SEPTIC SHOCK; SHOCK; SINGLE DRUG DOSE; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME; UNITED STATES; UNSPECIFIED SIDE EFFECT; URINE VOLUME;

EID: 84876296700     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.02.349     Document Type: Article

References (164)

1. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group KDIGO Clinical Practice Guideline for Acute Kidney Injury Kidney Int Suppl 2 2012 1 138
2. E.M. Levy, C.M. Viscoli, R.I. Horwitz The effect of acute renal failure on mortality A cohort analysis JAMA 275 19 1996 1489 1494
3. A. Lassnigg, D. Schmidlin, M. Mouhieddine Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study J Am Soc Nephrol 15 6 2004 1597 1605
4. G.M. Chertow, E. Burdick, M. Honour, J.V. Bonventre, D.W. Bates Acute kidney injury, mortality, length of stay, and costs in hospitalized patients J Am Soc Nephrol 16 11 2005 3365 3370
5. S. Uchino, R. Bellomo, D. Goldsmith, S. Bates, C. Ronco An assessment of the RIFLE criteria for acute renal failure in hospitalized patients Crit Care Med 34 7 2006 1913 1917
6. E.A. Hoste, J.A. Kellum Acute renal failure in the critically ill: impact on morbidity and mortality Contrib Nephrol 144 2004 1 11
7. R.L. Mehta, J.A. Kellum, S.V. Shah Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury Crit Care 11 2 2007 R31
8. A. Levin, D.G. Warnock, R.L. Mehta Improving outcomes from acute kidney injury: report of an initiative Am J Kidney Dis 50 1 2007 1 4
9. J.A. Kellum, R. Bellomo, C. Ronco The concept of acute kidney injury and the RIFLE criteria Contrib Nephrol 156 2007 10 16
10. S. Uchino The epidemiology of acute renal failure in the world Curr Opin Crit Care 12 6 2006 538 543
11. P.M. Palevsky, J.H. Zhang, T.Z. O'Connor Intensity of renal support in critically ill patients with acute kidney injury N Engl J Med 359 1 2008 7 20
12. R. Bellomo, A. Cass, L. Cole Intensity of continuous renal-replacement therapy in critically ill patients N Engl J Med 361 17 2009 1627 1638
13. L.J. Lo, A.S. Go, G.M. Chertow Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease Kidney Int 76 8 2009 893 899
14. A. Ishani, J.L. Xue, J. Himmelfarb Acute kidney injury increases risk of ESRD among elderly J Am Soc Nephrol 20 1 2009 223 228
15. R. Wald, R.R. Quinn, J. Luo Chronic dialysis and death among survivors of acute kidney injury requiring dialysis JAMA 302 11 2009 1179 1185
16. I.D. Bucaloiu, H.L. Kirchner, E.R. Norfolk, J.E. Hartle II, R.M. Perkins Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury Kidney Int 81 5 2012 477 485
17. R. Wald, R.R. Quinn, N.K. Adhikari Risk of chronic dialysis and death following acute kidney injury Am J Med 125 6 2012 585 593
18. R.L. Mehta, G.M. Chertow Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 14 8 2003 2178 2187
19. R. Bellomo, C. Ronco, J.A. Kellum, R.L. Mehta, P. Palevsky Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group Crit Care 8 4 2004 R204 R212
20. A. Akcan-Arikan, M. Zappitelli, L.L. Loftis, K.K. Washburn, L.S. Jefferson, S.L. Goldstein Modified RIFLE criteria in critically ill children with acute kidney injury Kidney Int 71 10 2007 1028 1035
21. AGREE Collaboration Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project Qual Saf Health Care 12 1 2003 18 23
22. M.C. Brouwers, M.E. Kho, G.P. Browman AGREE II: advancing guideline development, reporting and evaluation in health care J Clin Epidemiol 63 12 2010 1308 1311
23. AGREE Next Steps Consortium The AGREE II Instrument http://www. agreetrust.org 2009 Accessed October 2, 2012
24. Z. Ricci, D. Cruz, C. Ronco The RIFLE criteria and mortality in acute kidney injury: a systematic review Kidney Int 73 5 2008 538 546
25. J.O. Friedrich, N. Adhikari, M.S. Herridge, J. Beyene Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death Ann Intern Med 142 7 2005 510 524
26. R.L. Mehta, M.T. Pascual, S. Soroko, G.M. Chertow Diuretics, mortality, and nonrecovery of renal function in acute renal failure JAMA 288 20 2002 2547 2553
27. B.B. Newsome, D.G. Warnock, W.M. McClellan Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction Arch Intern Med 168 6 2008 609 616
28. S.G. Coca, J.T. King Jr, R.A. Rosenthal, M.F. Perkal, C.R. Parikh The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans Kidney Int 78 9 2010 926 933
29. L.S. Chawla, R.L. Amdur, S. Amodeo, P.L. Kimmel, C.E. Palant The severity of acute kidney injury predicts progression to chronic kidney disease Kidney Int 79 12 2011 1361 1369
30. M.T. James, W.A. Ghali, M.L. Knudtson Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography Circulation 123 4 2011 409 416
31. L.A. Greenbaum, A. Munoz, M.F. Schneider The association between abnormal birth history and growth in children with CKD Clin J Am Soc Nephrol 6 1 2011 14 21
32. F.M. Brunkhorst, C. Engel, F. Bloos Intensive insulin therapy and pentastarch resuscitation in severe sepsis N Engl J Med 358 2 2008 125 139
33. F. Schortgen, J.C. Lacherade, F. Bruneel Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study Lancet 357 9260 2001 911 916
34. J.A. Myburgh, S. Finfer, R. Bellomo Hydroxyethyl starch or saline for fluid resuscitation in intensive care N Engl J Med 367 20 2012 1901 1911
35. A. Perner, N. Haase, A.B. Guttormsen et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis N Engl J Med 367 2 2012 124 134
36. R. Zarychanski, A.M. Abou-Setta, A.F. Turgeon et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. A systematic review and meta-analysis JAMA 309 7 2013 678 688
37. S. Finfer, R. Bellomo, N. Boyce, J. French, J. Myburgh, R. Norton A comparison of albumin and saline for fluid resuscitation in the intensive care unit N Engl J Med 350 22 2004 2247 2256
38. J. Myburgh, D.J. Cooper, S. Finfer Saline or albumin for fluid resuscitation in patients with traumatic brain injury N Engl J Med 357 9 2007 874 884
39. P. Gines, L. Tito, V. Arroyo Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis Gastroenterology 94 6 1988 1493 1502
40. P. Sort, M. Navasa, V. Arroyo Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis N Engl J Med 341 6 1999 403 409
41. F. Salerno, A. Gerbes, P. Gines, F. Wong, V. Arroyo Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis Gut 56 9 2007 1310 1318
42. N.M. Yunos, R. Bellomo, C. Hegarty, D. Story, L. Ho, M. Bailey Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults JAMA 308 15 2012 1566 1572
43. A.D. Shaw, S.M. Bagshaw, S.L. Goldstein Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte Ann Surg 255 5 2012 821 829
44. D. De Backer, P. Biston, J. Devriendt Comparison of dopamine and norepinephrine in the treatment of shock N Engl J Med 362 9 2010 779 789
45. D. De Backer, C. Aldecoa, H. Njimi, J.L. Vincent Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis Crit Care Med 40 3 2012 725 730
46. T.S. Vasu, R. Cavallazzi, A. Hirani, G. Kaplan, B. Leiby, P.E. Marik Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials J Intensive Care Med 27 3 2012 172 178
47. E. Rivers, B. Nguyen, S. Havstad Early goal-directed therapy in the treatment of severe sepsis and septic shock N Engl J Med 345 19 2001 1368 1377
48. S.M. Lin, C.D. Huang, H.C. Lin, C.Y. Liu, C.H. Wang, H.P. Kuo A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial Shock 26 6 2006 551 557
49. A.E. Jones, A. Focht, J.M. Horton, J.A. Kline Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock Chest 132 2 2007 425 432
50. H.B. Nguyen, S.W. Corbett, K. Menes Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department Acad Emerg Med 13 1 2006 109 113
51. A. Rhodes, E.D. Bennett Early goal-directed therapy: an evidence-based review Crit Care Med 32 11(suppl) 2004 S448 S450
52. C.A. Crowe, C.D. Mistry, K. Rzechula, C.E. Kulstad Evaluation of a modified early goal-directed therapy protocol Am J Emerg Med 28 6 2010 689 693
53. N. Brienza, M.T. Giglio, M. Marucci, T. Fiore Does perioperative hemodynamic optimization protect renal function in surgical patients? A meta-analytic study Crit Care Med 37 6 2009 2079 2090
54. M.I. Rudis, M.A. Basha, B.J. Zarowitz Is it time to reposition vasopressors and inotropes in sepsis? Crit Care Med 24 3 1996 525 537
55. M. Egi, R. Bellomo, E. Stachowski The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes Crit Care Med 39 1 2011 105 111
56. E. Fiaccadori, U. Maggiore, R. Giacosa Enteral nutrition in patients with acute renal failure Kidney Int 65 3 2004 999 1008
57. M.P. Casaer, D. Mesotten, G. Hermans Early versus late parenteral nutrition in critically ill adults N Engl J Med 365 6 2011 506 517
58. T.W. Rice, A.P. Wheeler, B.T. Thompson Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial JAMA 307 8 2012 795 803
59. A.R. Davies, S.S. Morrison, M.J. Bailey A multicenter, randomized controlled trial comparing early nasojejunal with nasogastric nutrition in critical illness Crit Care Med 40 8 2012 2342 2348
60. N.M. Mehta, C. Compher A.S.P.E.N. Clinical Guidelines: nutrition support of the critically ill child JPEN J Parenter Enteral Nutr 33 3 2009 260 276
61. M. Zappitelli, S.L. Goldstein, J.M. Symons Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group Crit Care Med 36 12 2008 3239 3245
62. M. Schetz, T. Bove, A. Morelli, S. Mankad, C. Ronco, J.A. Kellum Prevention of cardiac surgery-associated acute kidney injury Int J Artif Organs 31 2 2008 179 189
63. R. Solomon, C. Werner, D. Mann, J. D'Elia, P. Silva Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents N Engl J Med 331 21 1994 1416 1420
64. S.R. Majumdar, C.M. Kjellstrand, W.J. Tymchak, M. Hervas-Malo, D.A. Taylor, K.K. Teo Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial Am J Kidney Dis 54 4 2009 602 609
65. C.V. Brown, P. Rhee, L. Chan, K. Evans, D. Demetriades, G.C. Velmahos Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference? J Trauma 56 6 2004 1191 1196
66. M.E. Grams, M.M. Estrella, J. Coresh, R.G. Brower, K.D. Liu Fluid balance, diuretic use, and mortality in acute kidney injury Clin J Am Soc Nephrol 6 5 2011 966 973
67. A.G. Jenik, J.M. Ceriani Cernadas, A. Gorenstein A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia Pediatrics 105 4 2000 E45
68. A.F. Bakr Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia - a study in a developing country Pediatr Nephrol 20 9 2005 1249 1252
69. M.A. Bhat, Z.A. Shah, M.S. Makhdoomi, M.H. Mufti Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial J Pediatr 149 2 2006 180 184
70. Z. Eslami, A. Shajari, M. Kheirandish, A. Heidary Theophylline for prevention of kidney dysfunction in neonates with severe asphyxia Iran J Kidney Dis 3 4 2009 222 226
71. M.J. Izquierdo, C. Gomez-Alamillo, F. Ortiz Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa Clin Nephrol 66 6 2006 464 467
72. C.A. Cannella, S.T. Wilkinson Acute renal failure associated with inhaled tobramycin Am J Health Syst Pharm 63 19 2006 1858 1861
73. R. Laporta, P. Ussetti, M.C. Carreno Renal toxicity due to inhaled tobramycin in lung transplant recipients J Heart Lung Transplant 25 5 2006 608
74. M. Kleinberg What is the current and future status of conventional amphotericin B? Int J Antimicrob Agents 27 suppl 1 2006 12 16
75. A.J. Ullmann, M.A. Sanz, A. Tramarin Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries Clin Infect Dis 43 4 2006 e29 e38
76. R.A. Branch Prevention of amphotericin B-induced renal impairment: a review of the use of sodium supplementation Arch Int Med 148 11 1988 2389 2394
77. C.V. Thakar, S. Arrigain, S. Worley, J.P. Yared, E.P. Paganini A clinical score to predict acute renal failure after cardiac surgery J Am Soc Nephrol 16 1 2005 162 168
78. D.N. Wijeysundera, K. Karkouti, J.Y. Dupuis Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery JAMA 297 16 2007 1801 1809
79. L.S. Chawla, Y. Zhao, F.C. Lough, E. Schroeder, M.G. Seneff, J.M. Brennan Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function J Am Soc Nephrol 23 8 2012 1389 1397
80. A.L. Shroyer, F.L. Grover, B. Hattler On-pump versus off-pump coronary-artery bypass surgery N Engl J Med 361 19 2009 1827 1837
81. A. Lamy, P.J. Devereaux, D. Prabhakaran Off-pump or on-pump coronary-artery bypass grafting at 30 days N Engl J Med 366 16 2012 1489 1497
82. P.L. Choyke, J. Cady, S.L. DePollar, H. Austin Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients? Tech Urol 4 2 1998 65 69
83. G.M. Chertow, S.L. Normand, B.J. McNeil "Renalism": inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency J Am Soc Nephrol 15 9 2004 2462 2468
84. U. Nyman, T. Almen, P. Aspelin, M. Hellstrom, M. Kristiansson, G. Sterner Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min Acta Radiol 46 8 2005 830 842
85. W.K. Laskey, C. Jenkins, F. Selzer Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention J Am Coll Cardiol 50 7 2007 584 590
86. U. Nyman, J. Bjork, P. Aspelin, G. Marenzi Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention Acta Radiol 49 6 2008 658 667
87. B.J. Barrett, E.J. Carlisle Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media Radiology 188 1 1993 171 178
88. P. Aspelin, P. Aubry, S.G. Fransson, R. Strasser, R. Willenbrock, K.J. Berg Nephrotoxic effects in high-risk patients undergoing angiography N Engl J Med 348 6 2003 491 499
89. M.C. Heinrich, L. Haberle, V. Muller, W. Bautz, M. Uder Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials Radiology 250 1 2009 68 86
90. F.G. Kushner, M. Hand, S.C. Smith Jr 2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (updating the 2005 Guideline and 2007 Focused Update): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Circulation 120 22 2009 2271 2306
91. G.J. Merten, W.P. Burgess, L.V. Gray Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 19 2004 2328 2334
92. C. Briguori, F. Airoldi, D. D'Andrea Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies Circulation 115 10 2007 1211 1217
93. M. Masuda, T. Yamada, T. Mine Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure Am J Cardiol 100 5 2007 781 786
94. E.E. Ozcan, S. Guneri, B. Akdeniz Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy A comparison of 3 regimens for protecting contrast-induced nephropathy in patients undergoing coronary procedures. A single-center prospective controlled trial Am Heart J 154 3 2007 539 544
95. M. Pakfetrat, M.H. Nikoo, L. Malekmakan A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial Int Urol Nephrol 41 3 2009 629 634
96. A. Recio-Mayoral, M. Chaparro, B. Prado The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study J Am Coll Cardiol 49 12 2007 1283 1288
97. S.S. Brar, A.Y. Shen, M.B. Jorgensen Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial JAMA 300 9 2008 1038 1046
98. M. Maioli, A. Toso, M. Leoncini Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention J Am Coll Cardiol 52 8 2008 599 604
99. A. Vasheghani-Farahani, G. Sadigh, S.E. Kassaian Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial Am J Kidney Dis 54 4 2009 610 618
100. J.R. Brown, C.A. Block, D.J. Malenka, G.T. O'Connor, A.C. Schoolwerth, C.A. Thompson Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis JACC Cardiovasc Interv 2 11 2009 1116 1124
101. S. Zoungas, T. Ninomiya, R. Huxley Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy Ann Intern Med 151 9 2009 631 638
102. S.D. Navaneethan, S. Singh, S. Appasamy, R.E. Wing, A.R. Sehgal Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Kidney Dis 53 4 2009 617 627
103. P. Meier, D.T. Ko, A. Tamura, U. Tamhane, H.S. Gurm Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis BMC Med 7 2009 23
104. E.A. Hoste, J.J. De Waele, S.A. Gevaert, S. Uchino, J.A. Kellum Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis Nephrol Dial Transplant 25 3 2010 747 758
105. M. Joannidis, M. Schmid, C.J. Wiedermann Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis Wien Klin Wochenschr 120 23-24 2008 742 748
106. S.E. Hogan, P. L'Allier, S. Chetcuti Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis Am Heart J 156 3 2008 414 421
107. K.M. Ho, D.J. Morgan Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis Anaesth Intensive Care 36 5 2008 646 653
108. M. Kanbay, A. Covic, S.G. Coca, F. Turgut, A. Akcay, C.R. Parikh Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials Int Urol Nephrol 41 3 2009 617 627
109. V. Kunadian, A. Zaman, I. Spyridopoulos, W. Qiu Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials Eur J Radiol 79 1 2011 48 55
110. S.S. Brar, S. Hiremath, G. Dangas, R. Mehran, S.K. Brar, M.B. Leon Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis Clin J Am Soc Nephrol 4 10 2009 1584 1592
111. C. Briguori, G. Visconti, A. Focaccio Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury Circulation 124 11 2011 1260 1269
112. G. Marenzi, C. Ferrari, I. Marana Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial JACC Cardiovasc Interv 5 1 2012 90 97
113. M. Tepel, M. van der Giet, C. Schwarzfeld, U. Laufer, D. Liermann, W. Zidek Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 3 2000 180 184
114. C.S. Baker, A. Wragg, S. Kumar, R. De Palma, L.R. Baker, C.J. Knight A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 12 2003 2114 2118
115. D.C. Balderramo, M.B. Verdu, C.F. Ramacciotti Renoprotective effect of high periprocedural doses of oral N-acetylcysteine in patients scheduled to undergo a same-day angiography Rev Fac Cien Med Univ Nac Cordoba 61 2 2004 13 19
116. L.J. Diaz-Sandoval, B.D. Kosowsky, D.W. Losordo Acetylcysteine to Prevent Angiography-Related Renal Tissue Injury (the APART trial) Am J Cardiol 89 3 2002 356 358
117. L.F. Drager, L. Andrade, J.F. Barros de Toledo, F.R. Laurindo, L.A. Machado Cesar, A.C. Seguro Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury Nephrol Dial Transplant 19 7 2004 1803 1807
118. J. Kay, W.H. Chow, T.M. Chan Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289 5 2003 553 558
119. B.D. MacNeill, S.A. Harding, H. Bazari Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography Catheter Cardiovasc Interv 60 4 2003 458 461
120. G. Marenzi, E. Assanelli, I. Marana N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 26 2006 2773 2782
121. S.E. Miner, V. Dzavik, P. Nguyen-Ho N-Acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up Am Heart J 148 4 2004 690 695
122. A. Ochoa, G. Pellizzon, S. Addala Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention J Interv Cardiol 17 3 2004 159 165
123. K.G. Shyu, J.J. Cheng, P. Kuan Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J Am Coll Cardiol 40 8 2002 1383 1388
124. S. Allaqaband, R. Tumuluri, A.M. Malik Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy Catheter Cardiovasc Interv 57 3 2002 279 283
125. M. Amini, M. Salarifar, A. Amirbaigloo, F. Masoudkabir, F. Esfahani N-Acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial Trials 10 2009 45
126. A.D. Azmus, C. Gottschall, A. Manica Effectiveness of acetylcysteine in prevention of contrast nephropathy J Invasive Cardiol 17 2 2005 80 84
127. C. Briguori, F. Manganelli, P. Scarpato Acetylcysteine and contrast agent-associated nephrotoxicity J Am Coll Cardiol 40 2 2002 298 303
128. N. Carbonell, M. Blasco, R. Sanjuan Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial Int J Cardiol 115 1 2007 57 62
129. L.C. Coyle, A. Rodriguez, R.E. Jeschke, A. Simon-Lee, K.C. Abbott, A.J. Taylor Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics Am Heart J 151 5 2006 1032.e9 1032.e12
130. J.D. Durham, C. Caputo, J. Dokko A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography Kidney Int 62 6 2002 2202 2207
131. J.W. Fung, C.C. Szeto, W.W. Chan Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial Am J Kidney Dis 43 5 2004 801 808
132. I. Goldenberg, M. Shechter, S. Matetzky Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography A randomized controlled trial and review of the current literature Eur Heart J 25 3 2004 212 218
133. V.O. Gomes, C.E. Poli de Figueredo, P. Caramori N-Acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial Heart 91 6 2005 774 778
134. J.M. Kefer, C.E. Hanet, S. Boitte, L. Wilmotte, M. De Kock Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient? Acta Cardiol 58 6 2003 555 560
135. J.B. Oldemeyer, W.P. Biddle, R.L. Wurdeman, A.N. Mooss, E. Cichowski, D.E. Hilleman Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography Am Heart J 146 6 2003 E23
136. S.T. Rashid, M. Salman, F. Myint Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine J Vasc Surg 40 6 2004 1136 1141
137. C. Sandhu, A.M. Belli, D.B. Oliveira The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity Cardiovasc Intervent Radiol 29 3 2006 344 347
138. J.G. Webb, G.E. Pate, K.H. Humphries A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect Am Heart J 148 3 2004 422 429
139. A.M. Kelly, B. Dwamena, P. Cronin, S.J. Bernstein, R.C. Carlos Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 4 2008 284 294
140. D.A. Gonzales, K.J. Norsworthy, S.J. Kern A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity BMC Med 5 2007 32
141. P.T. Vaitkus, C. Brar N-Acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses Am Heart J 153 2 2007 275 280
142. H. Trivedi, S. Daram, A. Szabo, A.L. Bartorelli, G. Marenzi High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy Am J Med 122 9 2009 874 e879-815
143. ACT Investigators Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT) Circulation 124 11 2011 1250 1259
144. G.W. Stone, P.A. McCullough, J.A. Tumlin Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial JAMA 290 17 2003 2284 2291
145. B. Dai, Y. Liu, L. Fu, Y. Li, J. Zhang, C. Mei Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials Am J Kidney Dis 60 3 2012 360 370
146. D.N. Cruz, C.Y. Goh, G. Marenzi, V. Corradi, C. Ronco, M.A. Perazella Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review Am J Med 125 1 2012 66 78 e63
147. J.J. Parienti, M. Thirion, B. Megarbane Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial JAMA 299 20 2008 2413 2422
148. M. Barenbrock, M. Hausberg, F. Matzkies, S. de la Motte, R.M. Schaefer Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients Kidney Int 58 4 2000 1751 1757
149. A.G. McLean, A. Davenport, D. Cox, P. Sweny Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction Kidney Int 58 4 2000 1765 1772
150. A.N. Thomas, J.M. Guy, R. Kishen, I.F. Geraghty, B.J. Bowles, P. Vadgama Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients Nephrol Dial Transplant 12 6 1997 1212 1217
151. F.A. Gotch, J.A. Sargent, M.L. Keen Whither goest Kt/V? Kidney Int Suppl 76 2000 S3 S18
152. J.A. Evanson, J. Himmelfarb, R. Wingard Prescribed versus delivered dialysis in acute renal failure patients Am J Kidney Dis 32 5 1998 731 738
153. R. Venkataraman, J.A. Kellum, P. Palevsky Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States J Crit Care 17 4 2002 246 250
154. P. Overberger, M. Pesacreta, P.M. Palevsky Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices Clin J Am Soc Nephrol 2 4 2007 623 630
155. S. Vesconi, D.N. Cruz, R. Fumagalli Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury Crit Care 13 2 2009 R57
156. A.J. Tolwani, M.B. Prendergast, R.R. Speer, B.S. Stofan, K.M. Wille A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance Clin J Am Soc Nephrol 1 1 2006 79 87
157. A. Tolwani, K.M. Wille Regional citrate anticoagulation for continuous renal replacement therapy: the better alternative? Am J Kidney Dis 59 6 2012 745 747
158. A. Link, M. Girndt, S. Selejan, A. Mathes, M. Bohm, H. Rensing Argatroban for anticoagulation in continuous renal replacement therapy Crit Care Med 37 1 2009 105 110
159. A.J. Tolwani, K.M. Wille Anticoagulation for continuous renal replacement therapy Semin Dial 22 2 2009 141 145
160. K. Klouche, L. Amigues, S. Deleuze, J.J. Beraud, B. Canaud Complications, effects on dialysis dose, and survival of tunneled femoral dialysis catheters in acute renal failure Am J Kidney Dis 49 1 2007 99 108
161. A. Davenport, E.J. Will, M.S. Losowsky, S. Swindells Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure Br Med J 295 6605 1987 1028
162. A. Davenport, H.J. Goldsmith Haemofiltration in management of patients with acute renal failure complicated by raised intracranial pressure Lancet 1 8526 1987 216
163. A. Davenport, E.J. Will, A.M. Davison Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure Nephrol Dial Transplant 5 3 1990 192 198
164. A. Davenport, E.J. Will, A.M. Davison Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema Contrib Nephrol 93 1991 225 233